nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—Epirubicin—pancreatic cancer	0.423	0.829	CbGbCtD
Orlistat—CYP3A4—Tamoxifen—pancreatic cancer	0.021	0.0412	CbGbCtD
Orlistat—CYP3A4—Erlotinib—pancreatic cancer	0.0179	0.035	CbGbCtD
Orlistat—CYP3A4—Irinotecan—pancreatic cancer	0.0161	0.0316	CbGbCtD
Orlistat—CYP3A4—Docetaxel—pancreatic cancer	0.0118	0.0232	CbGbCtD
Orlistat—CYP3A4—Sunitinib—pancreatic cancer	0.0118	0.0231	CbGbCtD
Orlistat—LIPF—digestive system—pancreatic cancer	0.0106	0.287	CbGeAlD
Orlistat—CYP3A4—Doxorubicin—pancreatic cancer	0.00882	0.0173	CbGbCtD
Orlistat—ABHD16A—islet of Langerhans—pancreatic cancer	0.00668	0.181	CbGeAlD
Orlistat—PNLIP—islet of Langerhans—pancreatic cancer	0.00626	0.17	CbGeAlD
Orlistat—ABHD16A—pancreas—pancreatic cancer	0.00469	0.127	CbGeAlD
Orlistat—PNLIP—pancreas—pancreatic cancer	0.0044	0.119	CbGeAlD
Orlistat—PNLIP—digestive system—pancreatic cancer	0.00376	0.102	CbGeAlD
Orlistat—FASN—Azacitidine—Gemcitabine—pancreatic cancer	0.00359	1	CbGdCrCtD
Orlistat—CYP3A4—digestive system—pancreatic cancer	0.0005	0.0136	CbGeAlD
Orlistat—Asthenia—Sunitinib—pancreatic cancer	0.000256	0.00104	CcSEcCtD
Orlistat—Dry skin—Epirubicin—pancreatic cancer	0.000256	0.00104	CcSEcCtD
Orlistat—Decreased appetite—Irinotecan—pancreatic cancer	0.000256	0.00104	CcSEcCtD
Orlistat—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000255	0.00104	CcSEcCtD
Orlistat—Insomnia—Fluorouracil—pancreatic cancer	0.000255	0.00104	CcSEcCtD
Orlistat—Hypokalaemia—Epirubicin—pancreatic cancer	0.000254	0.00104	CcSEcCtD
Orlistat—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000254	0.00104	CcSEcCtD
Orlistat—Fatigue—Irinotecan—pancreatic cancer	0.000254	0.00103	CcSEcCtD
Orlistat—Paraesthesia—Fluorouracil—pancreatic cancer	0.000253	0.00103	CcSEcCtD
Orlistat—Alopecia—Docetaxel—pancreatic cancer	0.000253	0.00103	CcSEcCtD
Orlistat—Pruritus—Sunitinib—pancreatic cancer	0.000253	0.00103	CcSEcCtD
Orlistat—Breast disorder—Epirubicin—pancreatic cancer	0.000252	0.00103	CcSEcCtD
Orlistat—Pain—Irinotecan—pancreatic cancer	0.000252	0.00103	CcSEcCtD
Orlistat—Mental disorder—Docetaxel—pancreatic cancer	0.000251	0.00102	CcSEcCtD
Orlistat—Malnutrition—Docetaxel—pancreatic cancer	0.000249	0.00102	CcSEcCtD
Orlistat—Decreased appetite—Gemcitabine—pancreatic cancer	0.000249	0.00102	CcSEcCtD
Orlistat—Dyspepsia—Fluorouracil—pancreatic cancer	0.000248	0.00101	CcSEcCtD
Orlistat—Nausea—Tamoxifen—pancreatic cancer	0.000248	0.00101	CcSEcCtD
Orlistat—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000248	0.00101	CcSEcCtD
Orlistat—Fatigue—Gemcitabine—pancreatic cancer	0.000247	0.00101	CcSEcCtD
Orlistat—Gastritis—Epirubicin—pancreatic cancer	0.000247	0.00101	CcSEcCtD
Orlistat—Pain—Gemcitabine—pancreatic cancer	0.000245	0.000999	CcSEcCtD
Orlistat—Nausea—Erlotinib—pancreatic cancer	0.000245	0.000999	CcSEcCtD
Orlistat—Decreased appetite—Fluorouracil—pancreatic cancer	0.000245	0.000998	CcSEcCtD
Orlistat—Diarrhoea—Sunitinib—pancreatic cancer	0.000244	0.000996	CcSEcCtD
Orlistat—Dysgeusia—Docetaxel—pancreatic cancer	0.000244	0.000994	CcSEcCtD
Orlistat—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000243	0.000991	CcSEcCtD
Orlistat—Abdominal distension—Epirubicin—pancreatic cancer	0.000243	0.00099	CcSEcCtD
Orlistat—Feeling abnormal—Irinotecan—pancreatic cancer	0.000243	0.000988	CcSEcCtD
Orlistat—Influenza—Epirubicin—pancreatic cancer	0.000241	0.000983	CcSEcCtD
Orlistat—Asthma—Epirubicin—pancreatic cancer	0.000241	0.000983	CcSEcCtD
Orlistat—Back pain—Docetaxel—pancreatic cancer	0.000241	0.000982	CcSEcCtD
Orlistat—Pain—Fluorouracil—pancreatic cancer	0.000241	0.000982	CcSEcCtD
Orlistat—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000241	0.00098	CcSEcCtD
Orlistat—Muscle spasms—Docetaxel—pancreatic cancer	0.00024	0.000976	CcSEcCtD
Orlistat—Dry skin—Doxorubicin—pancreatic cancer	0.000237	0.000965	CcSEcCtD
Orlistat—Pancreatitis—Epirubicin—pancreatic cancer	0.000237	0.000964	CcSEcCtD
Orlistat—Dizziness—Sunitinib—pancreatic cancer	0.000236	0.000962	CcSEcCtD
Orlistat—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000236	0.000962	CcSEcCtD
Orlistat—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000236	0.000961	CcSEcCtD
Orlistat—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000235	0.000958	CcSEcCtD
Orlistat—Breast disorder—Doxorubicin—pancreatic cancer	0.000233	0.000951	CcSEcCtD
Orlistat—Body temperature increased—Irinotecan—pancreatic cancer	0.000233	0.000948	CcSEcCtD
Orlistat—Abdominal pain—Irinotecan—pancreatic cancer	0.000233	0.000948	CcSEcCtD
Orlistat—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000232	0.000946	CcSEcCtD
Orlistat—Gastritis—Doxorubicin—pancreatic cancer	0.000229	0.000931	CcSEcCtD
Orlistat—Vomiting—Sunitinib—pancreatic cancer	0.000227	0.000925	CcSEcCtD
Orlistat—Body temperature increased—Gemcitabine—pancreatic cancer	0.000227	0.000923	CcSEcCtD
Orlistat—Rash—Sunitinib—pancreatic cancer	0.000225	0.000918	CcSEcCtD
Orlistat—Dermatitis—Sunitinib—pancreatic cancer	0.000225	0.000917	CcSEcCtD
Orlistat—Abdominal distension—Doxorubicin—pancreatic cancer	0.000225	0.000916	CcSEcCtD
Orlistat—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000224	0.000914	CcSEcCtD
Orlistat—Urticaria—Fluorouracil—pancreatic cancer	0.000224	0.000912	CcSEcCtD
Orlistat—Headache—Sunitinib—pancreatic cancer	0.000224	0.000912	CcSEcCtD
Orlistat—Influenza—Doxorubicin—pancreatic cancer	0.000223	0.00091	CcSEcCtD
Orlistat—Asthma—Doxorubicin—pancreatic cancer	0.000223	0.00091	CcSEcCtD
Orlistat—Body temperature increased—Fluorouracil—pancreatic cancer	0.000223	0.000908	CcSEcCtD
Orlistat—Palpitations—Docetaxel—pancreatic cancer	0.00022	0.000897	CcSEcCtD
Orlistat—Pancreatitis—Doxorubicin—pancreatic cancer	0.000219	0.000892	CcSEcCtD
Orlistat—Cough—Docetaxel—pancreatic cancer	0.000218	0.000886	CcSEcCtD
Orlistat—Hypersensitivity—Irinotecan—pancreatic cancer	0.000217	0.000883	CcSEcCtD
Orlistat—Convulsion—Docetaxel—pancreatic cancer	0.000216	0.00088	CcSEcCtD
Orlistat—Infestation NOS—Epirubicin—pancreatic cancer	0.000215	0.000876	CcSEcCtD
Orlistat—Infestation—Epirubicin—pancreatic cancer	0.000215	0.000876	CcSEcCtD
Orlistat—Chest pain—Docetaxel—pancreatic cancer	0.000212	0.000865	CcSEcCtD
Orlistat—Myalgia—Docetaxel—pancreatic cancer	0.000212	0.000865	CcSEcCtD
Orlistat—Nausea—Sunitinib—pancreatic cancer	0.000212	0.000865	CcSEcCtD
Orlistat—Renal failure—Epirubicin—pancreatic cancer	0.000212	0.000862	CcSEcCtD
Orlistat—Asthenia—Irinotecan—pancreatic cancer	0.000211	0.00086	CcSEcCtD
Orlistat—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000211	0.000859	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000211	0.000859	CcSEcCtD
Orlistat—Urinary tract infection—Epirubicin—pancreatic cancer	0.000209	0.000852	CcSEcCtD
Orlistat—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000208	0.000846	CcSEcCtD
Orlistat—Dry mouth—Docetaxel—pancreatic cancer	0.000208	0.000846	CcSEcCtD
Orlistat—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000208	0.000845	CcSEcCtD
Orlistat—Asthenia—Gemcitabine—pancreatic cancer	0.000206	0.000838	CcSEcCtD
Orlistat—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000203	0.000829	CcSEcCtD
Orlistat—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000203	0.000829	CcSEcCtD
Orlistat—Oedema—Docetaxel—pancreatic cancer	0.000203	0.000829	CcSEcCtD
Orlistat—Pruritus—Gemcitabine—pancreatic cancer	0.000203	0.000826	CcSEcCtD
Orlistat—Infection—Docetaxel—pancreatic cancer	0.000202	0.000823	CcSEcCtD
Orlistat—Sinusitis—Epirubicin—pancreatic cancer	0.000202	0.000822	CcSEcCtD
Orlistat—Diarrhoea—Irinotecan—pancreatic cancer	0.000201	0.00082	CcSEcCtD
Orlistat—Nervous system disorder—Docetaxel—pancreatic cancer	0.0002	0.000813	CcSEcCtD
Orlistat—Pruritus—Fluorouracil—pancreatic cancer	0.000199	0.000812	CcSEcCtD
Orlistat—Infestation—Doxorubicin—pancreatic cancer	0.000199	0.000811	CcSEcCtD
Orlistat—Infestation NOS—Doxorubicin—pancreatic cancer	0.000199	0.000811	CcSEcCtD
Orlistat—Skin disorder—Docetaxel—pancreatic cancer	0.000198	0.000805	CcSEcCtD
Orlistat—Diarrhoea—Gemcitabine—pancreatic cancer	0.000196	0.000799	CcSEcCtD
Orlistat—Renal failure—Doxorubicin—pancreatic cancer	0.000196	0.000797	CcSEcCtD
Orlistat—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000195	0.000795	CcSEcCtD
Orlistat—Dizziness—Irinotecan—pancreatic cancer	0.000195	0.000793	CcSEcCtD
Orlistat—Haemoglobin—Epirubicin—pancreatic cancer	0.000194	0.000791	CcSEcCtD
Orlistat—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000194	0.000788	CcSEcCtD
Orlistat—Hepatitis—Epirubicin—pancreatic cancer	0.000193	0.000787	CcSEcCtD
Orlistat—Haemorrhage—Epirubicin—pancreatic cancer	0.000193	0.000787	CcSEcCtD
Orlistat—Diarrhoea—Fluorouracil—pancreatic cancer	0.000193	0.000786	CcSEcCtD
Orlistat—Pharyngitis—Epirubicin—pancreatic cancer	0.000192	0.000781	CcSEcCtD
Orlistat—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000191	0.000777	CcSEcCtD
Orlistat—Oedema peripheral—Epirubicin—pancreatic cancer	0.00019	0.000775	CcSEcCtD
Orlistat—Urethral disorder—Epirubicin—pancreatic cancer	0.000189	0.000771	CcSEcCtD
Orlistat—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000188	0.000767	CcSEcCtD
Orlistat—Vomiting—Irinotecan—pancreatic cancer	0.000187	0.000762	CcSEcCtD
Orlistat—Sinusitis—Doxorubicin—pancreatic cancer	0.000187	0.000761	CcSEcCtD
Orlistat—Dizziness—Fluorouracil—pancreatic cancer	0.000186	0.000759	CcSEcCtD
Orlistat—Rash—Irinotecan—pancreatic cancer	0.000186	0.000756	CcSEcCtD
Orlistat—Dermatitis—Irinotecan—pancreatic cancer	0.000185	0.000755	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000185	0.000755	CcSEcCtD
Orlistat—Headache—Irinotecan—pancreatic cancer	0.000184	0.000751	CcSEcCtD
Orlistat—Insomnia—Docetaxel—pancreatic cancer	0.000184	0.00075	CcSEcCtD
Orlistat—Paraesthesia—Docetaxel—pancreatic cancer	0.000183	0.000744	CcSEcCtD
Orlistat—Vomiting—Gemcitabine—pancreatic cancer	0.000182	0.000743	CcSEcCtD
Orlistat—Rash—Gemcitabine—pancreatic cancer	0.000181	0.000736	CcSEcCtD
Orlistat—Dermatitis—Gemcitabine—pancreatic cancer	0.000181	0.000736	CcSEcCtD
Orlistat—Haemoglobin—Doxorubicin—pancreatic cancer	0.00018	0.000732	CcSEcCtD
Orlistat—Headache—Gemcitabine—pancreatic cancer	0.00018	0.000732	CcSEcCtD
Orlistat—Vomiting—Fluorouracil—pancreatic cancer	0.000179	0.00073	CcSEcCtD
Orlistat—Dyspepsia—Docetaxel—pancreatic cancer	0.000179	0.00073	CcSEcCtD
Orlistat—Haemorrhage—Doxorubicin—pancreatic cancer	0.000179	0.000728	CcSEcCtD
Orlistat—Hepatitis—Doxorubicin—pancreatic cancer	0.000179	0.000728	CcSEcCtD
Orlistat—Rash—Fluorouracil—pancreatic cancer	0.000178	0.000724	CcSEcCtD
Orlistat—Dermatitis—Fluorouracil—pancreatic cancer	0.000178	0.000723	CcSEcCtD
Orlistat—Pharyngitis—Doxorubicin—pancreatic cancer	0.000177	0.000723	CcSEcCtD
Orlistat—Decreased appetite—Docetaxel—pancreatic cancer	0.000177	0.00072	CcSEcCtD
Orlistat—Headache—Fluorouracil—pancreatic cancer	0.000177	0.000719	CcSEcCtD
Orlistat—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000176	0.000719	CcSEcCtD
Orlistat—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000176	0.000717	CcSEcCtD
Orlistat—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000176	0.000716	CcSEcCtD
Orlistat—Fatigue—Docetaxel—pancreatic cancer	0.000175	0.000715	CcSEcCtD
Orlistat—Urethral disorder—Doxorubicin—pancreatic cancer	0.000175	0.000714	CcSEcCtD
Orlistat—Nausea—Irinotecan—pancreatic cancer	0.000175	0.000712	CcSEcCtD
Orlistat—Immune system disorder—Epirubicin—pancreatic cancer	0.000174	0.000711	CcSEcCtD
Orlistat—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000174	0.000709	CcSEcCtD
Orlistat—Pain—Docetaxel—pancreatic cancer	0.000174	0.000709	CcSEcCtD
Orlistat—Alopecia—Epirubicin—pancreatic cancer	0.000171	0.000695	CcSEcCtD
Orlistat—Nausea—Gemcitabine—pancreatic cancer	0.00017	0.000694	CcSEcCtD
Orlistat—Mental disorder—Epirubicin—pancreatic cancer	0.000169	0.000689	CcSEcCtD
Orlistat—Malnutrition—Epirubicin—pancreatic cancer	0.000168	0.000685	CcSEcCtD
Orlistat—Feeling abnormal—Docetaxel—pancreatic cancer	0.000168	0.000683	CcSEcCtD
Orlistat—Nausea—Fluorouracil—pancreatic cancer	0.000167	0.000682	CcSEcCtD
Orlistat—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000166	0.000678	CcSEcCtD
Orlistat—Flatulence—Epirubicin—pancreatic cancer	0.000166	0.000675	CcSEcCtD
Orlistat—Dysgeusia—Epirubicin—pancreatic cancer	0.000165	0.000671	CcSEcCtD
Orlistat—Back pain—Epirubicin—pancreatic cancer	0.000163	0.000663	CcSEcCtD
Orlistat—Muscle spasms—Epirubicin—pancreatic cancer	0.000162	0.000659	CcSEcCtD
Orlistat—Immune system disorder—Doxorubicin—pancreatic cancer	0.000161	0.000658	CcSEcCtD
Orlistat—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000161	0.000656	CcSEcCtD
Orlistat—Body temperature increased—Docetaxel—pancreatic cancer	0.000161	0.000655	CcSEcCtD
Orlistat—Abdominal pain—Docetaxel—pancreatic cancer	0.000161	0.000655	CcSEcCtD
Orlistat—Vision blurred—Epirubicin—pancreatic cancer	0.000158	0.000646	CcSEcCtD
Orlistat—Alopecia—Doxorubicin—pancreatic cancer	0.000158	0.000643	CcSEcCtD
Orlistat—Mental disorder—Doxorubicin—pancreatic cancer	0.000157	0.000638	CcSEcCtD
Orlistat—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000156	0.000636	CcSEcCtD
Orlistat—Malnutrition—Doxorubicin—pancreatic cancer	0.000156	0.000634	CcSEcCtD
Orlistat—Flatulence—Doxorubicin—pancreatic cancer	0.000153	0.000624	CcSEcCtD
Orlistat—Dysgeusia—Doxorubicin—pancreatic cancer	0.000152	0.000621	CcSEcCtD
Orlistat—Malaise—Epirubicin—pancreatic cancer	0.000152	0.000618	CcSEcCtD
Orlistat—Vertigo—Epirubicin—pancreatic cancer	0.000151	0.000615	CcSEcCtD
Orlistat—Back pain—Doxorubicin—pancreatic cancer	0.00015	0.000613	CcSEcCtD
Orlistat—Hypersensitivity—Docetaxel—pancreatic cancer	0.00015	0.000611	CcSEcCtD
Orlistat—Muscle spasms—Doxorubicin—pancreatic cancer	0.00015	0.000609	CcSEcCtD
Orlistat—Palpitations—Epirubicin—pancreatic cancer	0.000149	0.000605	CcSEcCtD
Orlistat—Cough—Epirubicin—pancreatic cancer	0.000147	0.000598	CcSEcCtD
Orlistat—Vision blurred—Doxorubicin—pancreatic cancer	0.000147	0.000597	CcSEcCtD
Orlistat—Asthenia—Docetaxel—pancreatic cancer	0.000146	0.000595	CcSEcCtD
Orlistat—Convulsion—Epirubicin—pancreatic cancer	0.000146	0.000593	CcSEcCtD
Orlistat—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000144	0.000588	CcSEcCtD
Orlistat—Pruritus—Docetaxel—pancreatic cancer	0.000144	0.000586	CcSEcCtD
Orlistat—Myalgia—Epirubicin—pancreatic cancer	0.000143	0.000583	CcSEcCtD
Orlistat—Chest pain—Epirubicin—pancreatic cancer	0.000143	0.000583	CcSEcCtD
Orlistat—Anxiety—Epirubicin—pancreatic cancer	0.000143	0.000581	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000142	0.000579	CcSEcCtD
Orlistat—Discomfort—Epirubicin—pancreatic cancer	0.000141	0.000576	CcSEcCtD
Orlistat—Malaise—Doxorubicin—pancreatic cancer	0.00014	0.000572	CcSEcCtD
Orlistat—Dry mouth—Epirubicin—pancreatic cancer	0.00014	0.00057	CcSEcCtD
Orlistat—Vertigo—Doxorubicin—pancreatic cancer	0.00014	0.000569	CcSEcCtD
Orlistat—Diarrhoea—Docetaxel—pancreatic cancer	0.000139	0.000567	CcSEcCtD
Orlistat—Palpitations—Doxorubicin—pancreatic cancer	0.000137	0.00056	CcSEcCtD
Orlistat—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000137	0.000559	CcSEcCtD
Orlistat—Oedema—Epirubicin—pancreatic cancer	0.000137	0.000559	CcSEcCtD
Orlistat—Infection—Epirubicin—pancreatic cancer	0.000136	0.000555	CcSEcCtD
Orlistat—Cough—Doxorubicin—pancreatic cancer	0.000136	0.000553	CcSEcCtD
Orlistat—Convulsion—Doxorubicin—pancreatic cancer	0.000135	0.000549	CcSEcCtD
Orlistat—Nervous system disorder—Epirubicin—pancreatic cancer	0.000135	0.000548	CcSEcCtD
Orlistat—Dizziness—Docetaxel—pancreatic cancer	0.000135	0.000548	CcSEcCtD
Orlistat—Skin disorder—Epirubicin—pancreatic cancer	0.000133	0.000543	CcSEcCtD
Orlistat—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000133	0.00054	CcSEcCtD
Orlistat—Myalgia—Doxorubicin—pancreatic cancer	0.000132	0.00054	CcSEcCtD
Orlistat—Chest pain—Doxorubicin—pancreatic cancer	0.000132	0.00054	CcSEcCtD
Orlistat—Anxiety—Doxorubicin—pancreatic cancer	0.000132	0.000538	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000132	0.000536	CcSEcCtD
Orlistat—Discomfort—Doxorubicin—pancreatic cancer	0.000131	0.000533	CcSEcCtD
Orlistat—Dry mouth—Doxorubicin—pancreatic cancer	0.00013	0.000528	CcSEcCtD
Orlistat—Vomiting—Docetaxel—pancreatic cancer	0.000129	0.000527	CcSEcCtD
Orlistat—Rash—Docetaxel—pancreatic cancer	0.000128	0.000523	CcSEcCtD
Orlistat—Dermatitis—Docetaxel—pancreatic cancer	0.000128	0.000522	CcSEcCtD
Orlistat—Headache—Docetaxel—pancreatic cancer	0.000127	0.000519	CcSEcCtD
Orlistat—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000127	0.000517	CcSEcCtD
Orlistat—Oedema—Doxorubicin—pancreatic cancer	0.000127	0.000517	CcSEcCtD
Orlistat—Infection—Doxorubicin—pancreatic cancer	0.000126	0.000514	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000125	0.000509	CcSEcCtD
Orlistat—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000125	0.000507	CcSEcCtD
Orlistat—Insomnia—Epirubicin—pancreatic cancer	0.000124	0.000506	CcSEcCtD
Orlistat—Skin disorder—Doxorubicin—pancreatic cancer	0.000123	0.000502	CcSEcCtD
Orlistat—Paraesthesia—Epirubicin—pancreatic cancer	0.000123	0.000502	CcSEcCtD
Orlistat—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000123	0.0005	CcSEcCtD
Orlistat—Nausea—Docetaxel—pancreatic cancer	0.000121	0.000492	CcSEcCtD
Orlistat—Dyspepsia—Epirubicin—pancreatic cancer	0.000121	0.000492	CcSEcCtD
Orlistat—Decreased appetite—Epirubicin—pancreatic cancer	0.000119	0.000486	CcSEcCtD
Orlistat—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000118	0.000483	CcSEcCtD
Orlistat—Fatigue—Epirubicin—pancreatic cancer	0.000118	0.000482	CcSEcCtD
Orlistat—Pain—Epirubicin—pancreatic cancer	0.000117	0.000478	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000116	0.000471	CcSEcCtD
Orlistat—Insomnia—Doxorubicin—pancreatic cancer	0.000115	0.000468	CcSEcCtD
Orlistat—Paraesthesia—Doxorubicin—pancreatic cancer	0.000114	0.000464	CcSEcCtD
Orlistat—Feeling abnormal—Epirubicin—pancreatic cancer	0.000113	0.000461	CcSEcCtD
Orlistat—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000112	0.000457	CcSEcCtD
Orlistat—Dyspepsia—Doxorubicin—pancreatic cancer	0.000112	0.000455	CcSEcCtD
Orlistat—Decreased appetite—Doxorubicin—pancreatic cancer	0.00011	0.00045	CcSEcCtD
Orlistat—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00011	0.000447	CcSEcCtD
Orlistat—Fatigue—Doxorubicin—pancreatic cancer	0.000109	0.000446	CcSEcCtD
Orlistat—Urticaria—Epirubicin—pancreatic cancer	0.000109	0.000444	CcSEcCtD
Orlistat—Pain—Doxorubicin—pancreatic cancer	0.000109	0.000442	CcSEcCtD
Orlistat—Abdominal pain—Epirubicin—pancreatic cancer	0.000108	0.000442	CcSEcCtD
Orlistat—Body temperature increased—Epirubicin—pancreatic cancer	0.000108	0.000442	CcSEcCtD
Orlistat—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000105	0.000426	CcSEcCtD
Orlistat—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000104	0.000423	CcSEcCtD
Orlistat—Hypersensitivity—Epirubicin—pancreatic cancer	0.000101	0.000412	CcSEcCtD
Orlistat—Urticaria—Doxorubicin—pancreatic cancer	0.000101	0.000411	CcSEcCtD
Orlistat—Abdominal pain—Doxorubicin—pancreatic cancer	0.0001	0.000409	CcSEcCtD
Orlistat—Body temperature increased—Doxorubicin—pancreatic cancer	0.0001	0.000409	CcSEcCtD
Orlistat—Asthenia—Epirubicin—pancreatic cancer	9.85e-05	0.000401	CcSEcCtD
Orlistat—Pruritus—Epirubicin—pancreatic cancer	9.71e-05	0.000395	CcSEcCtD
Orlistat—Diarrhoea—Epirubicin—pancreatic cancer	9.39e-05	0.000382	CcSEcCtD
Orlistat—Hypersensitivity—Doxorubicin—pancreatic cancer	9.35e-05	0.000381	CcSEcCtD
Orlistat—Asthenia—Doxorubicin—pancreatic cancer	9.11e-05	0.000371	CcSEcCtD
Orlistat—Dizziness—Epirubicin—pancreatic cancer	9.07e-05	0.00037	CcSEcCtD
Orlistat—Pruritus—Doxorubicin—pancreatic cancer	8.98e-05	0.000366	CcSEcCtD
Orlistat—Vomiting—Epirubicin—pancreatic cancer	8.73e-05	0.000355	CcSEcCtD
Orlistat—Diarrhoea—Doxorubicin—pancreatic cancer	8.69e-05	0.000354	CcSEcCtD
Orlistat—Rash—Epirubicin—pancreatic cancer	8.65e-05	0.000352	CcSEcCtD
Orlistat—Dermatitis—Epirubicin—pancreatic cancer	8.64e-05	0.000352	CcSEcCtD
Orlistat—Headache—Epirubicin—pancreatic cancer	8.6e-05	0.00035	CcSEcCtD
Orlistat—Dizziness—Doxorubicin—pancreatic cancer	8.4e-05	0.000342	CcSEcCtD
Orlistat—Nausea—Epirubicin—pancreatic cancer	8.15e-05	0.000332	CcSEcCtD
Orlistat—Vomiting—Doxorubicin—pancreatic cancer	8.07e-05	0.000329	CcSEcCtD
Orlistat—Rash—Doxorubicin—pancreatic cancer	8.01e-05	0.000326	CcSEcCtD
Orlistat—Dermatitis—Doxorubicin—pancreatic cancer	8e-05	0.000326	CcSEcCtD
Orlistat—Headache—Doxorubicin—pancreatic cancer	7.95e-05	0.000324	CcSEcCtD
Orlistat—Nausea—Doxorubicin—pancreatic cancer	7.54e-05	0.000307	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—NOTCH1—pancreatic cancer	6.06e-05	0.000298	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SSTR2—pancreatic cancer	5.98e-05	0.000294	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PLAU—pancreatic cancer	5.97e-05	0.000294	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.93e-05	0.000292	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CG—pancreatic cancer	5.93e-05	0.000292	CbGpPWpGaD
Orlistat—FASN—Disease—EGF—pancreatic cancer	5.92e-05	0.000291	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.89e-05	0.000289	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EGF—pancreatic cancer	5.86e-05	0.000288	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCKBR—pancreatic cancer	5.77e-05	0.000284	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—SST—pancreatic cancer	5.76e-05	0.000283	CbGpPWpGaD
Orlistat—PNLIP—Disease—CTNNB1—pancreatic cancer	5.75e-05	0.000283	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—PIK3CA—pancreatic cancer	5.66e-05	0.000278	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—PIK3CA—pancreatic cancer	5.66e-05	0.000278	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	5.65e-05	0.000278	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTEN—pancreatic cancer	5.61e-05	0.000276	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—pancreatic cancer	5.56e-05	0.000273	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CB—pancreatic cancer	5.48e-05	0.00027	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CB—pancreatic cancer	5.48e-05	0.00027	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CB—pancreatic cancer	5.43e-05	0.000267	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GLI1—pancreatic cancer	5.43e-05	0.000267	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DTX4—pancreatic cancer	5.43e-05	0.000267	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.41e-05	0.000266	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—pancreatic cancer	5.38e-05	0.000265	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.36e-05	0.000263	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CNR1—pancreatic cancer	5.31e-05	0.000261	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CG—pancreatic cancer	5.31e-05	0.000261	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PPP2R5B—pancreatic cancer	5.28e-05	0.00026	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NRP1—pancreatic cancer	5.28e-05	0.00026	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—pancreatic cancer	5.27e-05	0.000259	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—pancreatic cancer	5.27e-05	0.000259	CbGpPWpGaD
Orlistat—FASN—Disease—PIK3CD—pancreatic cancer	5.27e-05	0.000259	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.26e-05	0.000259	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EGF—pancreatic cancer	5.25e-05	0.000258	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HRAS—pancreatic cancer	5.23e-05	0.000257	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HRAS—pancreatic cancer	5.23e-05	0.000257	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GLP1R—pancreatic cancer	5.23e-05	0.000257	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.23e-05	0.000257	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CD—pancreatic cancer	5.21e-05	0.000256	CbGpPWpGaD
Orlistat—PNLIP—Disease—SRC—pancreatic cancer	5.2e-05	0.000256	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DPYD—pancreatic cancer	5.15e-05	0.000253	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GCG—pancreatic cancer	5.13e-05	0.000252	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AKT1—pancreatic cancer	5.09e-05	0.00025	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AKT1—pancreatic cancer	5.09e-05	0.00025	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HEY2—pancreatic cancer	5.08e-05	0.00025	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CASP3—pancreatic cancer	5.04e-05	0.000248	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CASP3—pancreatic cancer	5.04e-05	0.000248	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CG—pancreatic cancer	5.02e-05	0.000247	CbGpPWpGaD
Orlistat—PNLIP—Disease—STAT3—pancreatic cancer	5.01e-05	0.000247	CbGpPWpGaD
Orlistat—PNLIP—Disease—NRAS—pancreatic cancer	5e-05	0.000246	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GAST—pancreatic cancer	4.96e-05	0.000244	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCND1—pancreatic cancer	4.91e-05	0.000241	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCND1—pancreatic cancer	4.91e-05	0.000241	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AGTR1—pancreatic cancer	4.9e-05	0.000241	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC2A2—pancreatic cancer	4.88e-05	0.00024	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CTNNB1—pancreatic cancer	4.86e-05	0.000239	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CTNNB1—pancreatic cancer	4.86e-05	0.000239	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—pancreatic cancer	4.84e-05	0.000238	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.83e-05	0.000238	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	4.81e-05	0.000237	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—pancreatic cancer	4.77e-05	0.000234	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—pancreatic cancer	4.77e-05	0.000234	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PTEN—pancreatic cancer	4.74e-05	0.000233	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTEN—pancreatic cancer	4.74e-05	0.000233	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SCT—pancreatic cancer	4.71e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HEY1—pancreatic cancer	4.71e-05	0.000231	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTEN—pancreatic cancer	4.69e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CD—pancreatic cancer	4.67e-05	0.00023	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.67e-05	0.000229	CbGpPWpGaD
Orlistat—PNLIP—Disease—MYC—pancreatic cancer	4.66e-05	0.000229	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—pancreatic cancer	4.65e-05	0.000229	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AKT1—pancreatic cancer	4.62e-05	0.000227	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AKT1—pancreatic cancer	4.62e-05	0.000227	CbGpPWpGaD
Orlistat—FASN—Disease—PIK3CB—pancreatic cancer	4.59e-05	0.000226	CbGpPWpGaD
Orlistat—PNLIP—Disease—EGFR—pancreatic cancer	4.56e-05	0.000224	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—pancreatic cancer	4.55e-05	0.000224	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CB—pancreatic cancer	4.54e-05	0.000223	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCK—pancreatic cancer	4.49e-05	0.000221	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.42e-05	0.000217	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CD—pancreatic cancer	4.41e-05	0.000217	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SRC—pancreatic cancer	4.39e-05	0.000216	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SRC—pancreatic cancer	4.39e-05	0.000216	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CNR2—pancreatic cancer	4.37e-05	0.000215	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GLP1R—pancreatic cancer	4.37e-05	0.000215	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—pancreatic cancer	4.37e-05	0.000215	CbGpPWpGaD
Orlistat—PNLIP—Disease—KRAS—pancreatic cancer	4.3e-05	0.000212	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCKAR—pancreatic cancer	4.3e-05	0.000212	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—pancreatic cancer	4.28e-05	0.00021	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—pancreatic cancer	4.28e-05	0.00021	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.25e-05	0.000209	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—STAT3—pancreatic cancer	4.24e-05	0.000208	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—STAT3—pancreatic cancer	4.24e-05	0.000208	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NRAS—pancreatic cancer	4.23e-05	0.000208	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NRAS—pancreatic cancer	4.23e-05	0.000208	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CASP3—pancreatic cancer	4.18e-05	0.000206	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JAG2—pancreatic cancer	4.17e-05	0.000205	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MEN1—pancreatic cancer	4.11e-05	0.000202	CbGpPWpGaD
Orlistat—FASN—Disease—CTNNB1—pancreatic cancer	4.07e-05	0.0002	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CB—pancreatic cancer	4.07e-05	0.0002	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCND1—pancreatic cancer	4.07e-05	0.0002	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CTNNB1—pancreatic cancer	4.03e-05	0.000198	CbGpPWpGaD
Orlistat—FASN—Disease—PTEN—pancreatic cancer	3.97e-05	0.000195	CbGpPWpGaD
Orlistat—PNLIP—Disease—PIK3CA—pancreatic cancer	3.95e-05	0.000195	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—pancreatic cancer	3.95e-05	0.000194	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MYC—pancreatic cancer	3.94e-05	0.000194	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MYC—pancreatic cancer	3.94e-05	0.000194	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.93e-05	0.000193	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—pancreatic cancer	3.93e-05	0.000193	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—pancreatic cancer	3.93e-05	0.000193	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PTEN—pancreatic cancer	3.93e-05	0.000193	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SHH—pancreatic cancer	3.92e-05	0.000193	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH4—pancreatic cancer	3.9e-05	0.000192	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IAPP—pancreatic cancer	3.87e-05	0.000191	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EGFR—pancreatic cancer	3.85e-05	0.000189	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EGFR—pancreatic cancer	3.85e-05	0.000189	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CB—pancreatic cancer	3.84e-05	0.000189	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—pancreatic cancer	3.81e-05	0.000187	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CD44—pancreatic cancer	3.78e-05	0.000186	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTHLH—pancreatic cancer	3.72e-05	0.000183	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTCH1—pancreatic cancer	3.72e-05	0.000183	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.7e-05	0.000182	CbGpPWpGaD
Orlistat—FASN—Disease—SRC—pancreatic cancer	3.68e-05	0.000181	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.67e-05	0.00018	CbGpPWpGaD
Orlistat—PNLIP—Disease—HRAS—pancreatic cancer	3.66e-05	0.00018	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SRC—pancreatic cancer	3.64e-05	0.000179	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KRAS—pancreatic cancer	3.64e-05	0.000179	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KRAS—pancreatic cancer	3.64e-05	0.000179	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GCG—pancreatic cancer	3.63e-05	0.000178	CbGpPWpGaD
Orlistat—FASN—Disease—STAT3—pancreatic cancer	3.55e-05	0.000174	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—pancreatic cancer	3.55e-05	0.000174	CbGpPWpGaD
Orlistat—FASN—Disease—NRAS—pancreatic cancer	3.54e-05	0.000174	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—STAT3—pancreatic cancer	3.51e-05	0.000173	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NRAS—pancreatic cancer	3.5e-05	0.000172	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—STK11—pancreatic cancer	3.41e-05	0.000168	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SST—pancreatic cancer	3.4e-05	0.000167	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CA—pancreatic cancer	3.34e-05	0.000164	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CA—pancreatic cancer	3.34e-05	0.000164	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JAG1—pancreatic cancer	3.33e-05	0.000164	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTEN—pancreatic cancer	3.32e-05	0.000163	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH3—pancreatic cancer	3.32e-05	0.000163	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CA—pancreatic cancer	3.31e-05	0.000163	CbGpPWpGaD
Orlistat—FASN—Disease—MYC—pancreatic cancer	3.3e-05	0.000162	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—pancreatic cancer	3.29e-05	0.000162	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MYC—pancreatic cancer	3.26e-05	0.00016	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SRC—pancreatic cancer	3.26e-05	0.00016	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—pancreatic cancer	3.25e-05	0.00016	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—pancreatic cancer	3.23e-05	0.000159	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—pancreatic cancer	3.23e-05	0.000159	CbGpPWpGaD
Orlistat—PNLIP—Disease—AKT1—pancreatic cancer	3.23e-05	0.000159	CbGpPWpGaD
Orlistat—FASN—Disease—EGFR—pancreatic cancer	3.22e-05	0.000159	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.2e-05	0.000157	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EGFR—pancreatic cancer	3.19e-05	0.000157	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—pancreatic cancer	3.18e-05	0.000156	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CNR1—pancreatic cancer	3.14e-05	0.000154	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NRAS—pancreatic cancer	3.14e-05	0.000154	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HRAS—pancreatic cancer	3.09e-05	0.000152	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HRAS—pancreatic cancer	3.09e-05	0.000152	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.05e-05	0.00015	CbGpPWpGaD
Orlistat—FASN—Disease—KRAS—pancreatic cancer	3.05e-05	0.00015	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GCG—pancreatic cancer	3.03e-05	0.000149	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—KRAS—pancreatic cancer	3.01e-05	0.000148	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TYMS—pancreatic cancer	2.93e-05	0.000144	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—pancreatic cancer	2.91e-05	0.000143	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGTR1—pancreatic cancer	2.89e-05	0.000142	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STK11—pancreatic cancer	2.85e-05	0.00014	CbGpPWpGaD
Orlistat—FASN—Disease—PIK3CA—pancreatic cancer	2.8e-05	0.000138	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CA—pancreatic cancer	2.77e-05	0.000136	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AKT1—pancreatic cancer	2.73e-05	0.000134	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AKT1—pancreatic cancer	2.73e-05	0.000134	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AKT1—pancreatic cancer	2.71e-05	0.000133	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—KRAS—pancreatic cancer	2.7e-05	0.000133	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—pancreatic cancer	2.68e-05	0.000132	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.68e-05	0.000132	CbGpPWpGaD
Orlistat—FASN—Disease—HRAS—pancreatic cancer	2.59e-05	0.000127	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HRAS—pancreatic cancer	2.56e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SMAD4—pancreatic cancer	2.5e-05	0.000123	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CA—pancreatic cancer	2.48e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HES1—pancreatic cancer	2.44e-05	0.00012	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—pancreatic cancer	2.4e-05	0.000118	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—pancreatic cancer	2.39e-05	0.000117	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CA—pancreatic cancer	2.34e-05	0.000115	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.33e-05	0.000115	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HRAS—pancreatic cancer	2.29e-05	0.000113	CbGpPWpGaD
Orlistat—FASN—Disease—AKT1—pancreatic cancer	2.29e-05	0.000112	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AKT1—pancreatic cancer	2.26e-05	0.000111	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.26e-05	0.000111	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—pancreatic cancer	2.24e-05	0.00011	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CG—pancreatic cancer	2.15e-05	0.000106	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TERT—pancreatic cancer	2.14e-05	0.000105	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—pancreatic cancer	2.08e-05	0.000102	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HIF1A—pancreatic cancer	2.04e-05	0.0001	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TSC2—pancreatic cancer	2.04e-05	0.0001	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—AKT1—pancreatic cancer	2.03e-05	9.96e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.01e-05	9.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—pancreatic cancer	1.99e-05	9.81e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KDR—pancreatic cancer	1.95e-05	9.61e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKT1—pancreatic cancer	1.91e-05	9.41e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CD—pancreatic cancer	1.89e-05	9.31e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKBIA—pancreatic cancer	1.86e-05	9.14e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH1—pancreatic cancer	1.84e-05	9.05e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CG—pancreatic cancer	1.8e-05	8.85e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NRAS—pancreatic cancer	1.8e-05	8.85e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EGF—pancreatic cancer	1.78e-05	8.75e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.74e-05	8.55e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CB—pancreatic cancer	1.65e-05	8.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EGFR—pancreatic cancer	1.64e-05	8.07e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—pancreatic cancer	1.63e-05	8.04e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CD—pancreatic cancer	1.58e-05	7.78e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—KRAS—pancreatic cancer	1.55e-05	7.62e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.52e-05	7.48e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTEN—pancreatic cancer	1.43e-05	7.01e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.42e-05	7e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CB—pancreatic cancer	1.38e-05	6.78e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—pancreatic cancer	1.33e-05	6.52e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HRAS—pancreatic cancer	1.32e-05	6.48e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CASP3—pancreatic cancer	1.27e-05	6.24e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	6.07e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.23e-05	6.03e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CTNNB1—pancreatic cancer	1.22e-05	6.01e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.21e-05	5.93e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—pancreatic cancer	1.2e-05	5.9e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTEN—pancreatic cancer	1.19e-05	5.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AKT1—pancreatic cancer	1.16e-05	5.72e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.14e-05	5.63e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SRC—pancreatic cancer	1.11e-05	5.44e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—pancreatic cancer	1.08e-05	5.29e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STAT3—pancreatic cancer	1.07e-05	5.24e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	5.23e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CA—pancreatic cancer	1.01e-05	4.95e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MYC—pancreatic cancer	9.9e-06	4.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—pancreatic cancer	9.88e-06	4.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EGFR—pancreatic cancer	9.69e-06	4.76e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KRAS—pancreatic cancer	9.15e-06	4.5e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CD44—pancreatic cancer	8.86e-06	4.36e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCG—pancreatic cancer	8.49e-06	4.18e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CA—pancreatic cancer	8.41e-06	4.14e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKT1—pancreatic cancer	8.21e-06	4.04e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—pancreatic cancer	8.13e-06	4e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—STK11—pancreatic cancer	7.98e-06	3.93e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HRAS—pancreatic cancer	7.78e-06	3.83e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.87e-06	3.38e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKT1—pancreatic cancer	6.87e-06	3.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—pancreatic cancer	5.59e-06	2.75e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.04e-06	2.48e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.87e-06	2.39e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.43e-06	2.18e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.86e-06	1.9e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.83e-06	1.88e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.34e-06	1.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.35e-06	1.16e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.92e-06	9.46e-06	CbGpPWpGaD
